2019 | Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia | Ooi C.J.; Hilmi I.; Banerjee R.; Chuah S.W.; Ng S.C.; SHU-CHEN WEI ; Makharia G.K.; Pisespongsa P.; Chen M.H.; Ran Z.H.; Ye B.D.; Park D.I.; Ling K.L.; Ong D.; Ahuja V.; Goh K.L.; Sollano J.; Lim W.C.; Leung W.K.; Ali R.A.R.; Wu D.C.; Ong E.; Mustaffa N.; Limsrivilai J.; Hisamatsu T.; Yang S.K.; Ouyang Q.; Geary R.; De Silva J.H.; Rerknimitr R.; Simadibrata M.; Abdullah M.; Leong R.W.L.; on behalf of the Asia-Pacific Association of Gastroenterology (APAGE) Working Group on Inflammatory Bowel Disease; Asian Organization for Crohn's; Colitis | Journal of Gastroenterology and Hepatology (Australia) | 40 | 24 | |